-
Impact of Real-World Effectiveness vs. Previous Assumptions on Estimates of Economic and Clinical Benefit of 20-Valent Pneumococcal Conjugate Vaccine in Adults Across Countries
Sep 9, 2025, 16:22 PM -
Costs and Healthcare Resource Utilization Associated With Generalized Myasthenia Gravis: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Disease Progression Modeling for an Ultra-Rare Disease: Lysosomal Acid Lipase Deficiency (LAL-D)
Sep 9, 2025, 16:22 PM -
Associations of Product-Specific and Clinical Evidence Quality Characteristics With Health Technology Assessment Outcomes: A Quantitative Assessment of Appraisals for Drugs for Rare Diseases in England and Germany
Sep 9, 2025, 16:22 PM -
Pricing Analysis of Value-Added Medicines (VAMs) in Europe: A Call for Recognition of Patient-Centric Innovation
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Surfactant Therapy for Neonatal Respiratory Distress Syndrome: 5-Year Real-World Evidence on Poractant Alfa vs. Beractant From the IMSS Perspective in Mexico
Sep 9, 2025, 16:22 PM -
From GVD to HTA: Preparing for Success in the EU JCA Era With GenAI-Enhanced Efficiency
Sep 9, 2025, 16:22 PM -
Estimating the Eligible Population for Anti-Amyloid Therapy in Finland
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective
Sep 9, 2025, 16:22 PM -
How Cost-Effectiveness and Budget Impact Drive Pricing and Reimbursement: Insights From an International Comparative Study
Sep 9, 2025, 16:22 PM -
Pegunigalsidase Alfa Elfabrio® as a Long-Term Enzyme Replacement Therapy in Adults With Fabry Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Organizational and Environmental Impact of Switching From Intravenous to Subcutaneous Immune Checkpoint Inhibitors (ICIs) in France: A Real-World Analysis Using PMSI Data
Sep 9, 2025, 16:22 PM -
A Collection Of Essays on Patient Centricity in Intervention Development
Sep 9, 2025, 16:22 PM -
Understanding Trends and Opinions on More Environmentally Friendly Healthcare: A Clinician Survey
Sep 9, 2025, 16:22 PM -
Comparing the Time to Reimbursement of the Orphan Drug Evrysdi in Turkiye vs. Euro-5 Markets
Sep 9, 2025, 16:22 PM -
Incidence of Adverse Events and Costs Among Patients Initiating Treatment for Myasthenia Gravis: A Real-World Analysis
Sep 9, 2025, 16:22 PM -
An Early Cost-Effectiveness Model for a Digital Community-Based Approach for Streamlined Audiology Care
Sep 9, 2025, 16:22 PM -
Give Us the Tools and We Will Finish the Job: How Accurate Is AI for Study Selection in Systematic Reviews?
Sep 9, 2025, 16:22 PM -
Evolving Trends in Patient Demographics and Diagnosis in Gastric Cancer: A Real-World Analysis From US Community Oncology Practices From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Use of RWE in HTA Submissions: A Systematic Review of Case Studies Across Three HTA Agencies Reveals Continued Concerns Around Internal Validity and Unmeasured Confounding
Sep 9, 2025, 16:22 PM
